<DOC>
	<DOCNO>NCT02690129</DOCNO>
	<brief_summary>The purpose study assess efficacy vaginal micronized progesterone treatment threaten miscarriage . All eligible pregnant woman randomize either receive vaginal progesterone treatment.Evaluation two week intervention , every 4 week 28 week gestation termination pregnancy .</brief_summary>
	<brief_title>Vaginal Progesterone Treatment Threatened Miscarriage</brief_title>
	<detailed_description />
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Abortion , Threatened</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>1 . Pregnant gestational age le 24 week 2 . Presented bleed without pain 3 . Single viable fetus ( confirm Ultrasound examination ) 4 . Accepting vaginal medication 1 . Currently medication chronic disease ( DM , thyroid , liver , renal , cardiac autoimmune disease ) . 2 . Hypersensitivity progesterone 3 . Any documented congenital fetal anomaly current pregnancy 4 . Women receive hormonal treatment current pregnancy 5 . Patients conceive via ART</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>progesterone</keyword>
	<keyword>threaten abortion</keyword>
</DOC>